Steven Cohen’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
KCM
KCM
6CM
Steven Cohen's ALDX Position: Q3 2026 in Review
Steven Cohen reduced its Aldeyra Therapeutics (ALDX) stake by 59% in Q3 2026, selling an estimated $145K and leaving 63,465 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.
Steven Cohen first reported a position in ALDX in Q2 2019 and has held it in 7 quarters since. The position peaked at $5.89M in Q4 2020. 97 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.
- Steven Cohen held 63,465 shares of Aldeyra Therapeutics worth $78.1K as of Q3 2026.
- Steven Cohen sold 90,943 Aldeyra Therapeutics shares in Q3 2026, an estimated $145K.
- Aldeyra Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3697 holding.
- Steven Cohen first reported a position in Aldeyra Therapeutics in Q2 2019 and has held it in 7 quarters since.
- Steven Cohen's Aldeyra Therapeutics position peaked at $5.89M in Q4 2020.
- 97 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.